European Neuropsychopharmacology Volume 78 to 79

Europeanis the official publication of the European College of Neuropsychopharmacology (ECNP). As the official journal, it aligns closely with the mission and goals of ECNP, which focus on advancing our understanding of brain function and human behavior. Here are some key features and areas of focus for European Neuropsychopharmacology:

1. Official Journal of ECNP: The journal proudly serves as the official publication of the European College of Neuropsychopharmacology. It plays a pivotal role in disseminating research and advancements related to neuropsychopharmacology within the context of ECNP’s mission.

2. Advancing Understanding of Brain Function and Behavior: European Neuropsychopharmacology places a strong emphasis on contributions from both clinical and basic science that enhance our comprehension of brain function and human behavior. It aims to facilitate a deeper understanding of the biological underpinnings of mental disorders.

3. Translation into Improved Treatments: While there have been significant advances in neuroscience and genomics in recent years, the translation of these findings into clinical treatments has been somewhat limited. The journal seeks to bridge this gap by promoting research that has the potential to significantly impact our understanding of mental disorders and the development of improved treatments.

4. Prevention and Recovery: European Neuropsychopharmacology aspires to pave the way for prevention and recovery in the realm of mental health. It is not solely focused on treatment but also aims to explore avenues for prevention and support individuals on the path to recovery.

5. Clinical and Basic Science Contributions: The journal welcomes contributions from both clinical and basic science domains. This multidisciplinary approach allows for a comprehensive exploration of neuropsychopharmacology, from fundamental research to clinical applications.

serves as an essential platform for researchers, clinicians, and professionals interested in neuropsychopharmacology. It facilitates the dissemination of critical research findings, promotes collaboration, and ultimately aims to improve mental health outcomes and public health impact in the field of psychiatry.

Volume 78: Pages 1-94 (January 2024)

Volume 79: Pages 1-78 (February 2024)